These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11585855)

  • 21. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.
    Imabayashi E; Matsuda H; Asada T; Ohnishi T; Sakamoto S; Nakano S; Inoue T
    J Nucl Med; 2004 Sep; 45(9):1450-7. PubMed ID: 15347711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
    Gungor HA; Yildiz A; Aydin F; Gungor F; Boz A; Ozkaynak S
    J Neurol Sci; 2005 Jul; 234(1-2):47-53. PubMed ID: 15950243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractal analysis of cerebral blood flow distribution in Alzheimer's disease.
    Kuikka JT
    J Nucl Med; 2002 Dec; 43(12):1727-8; author reply 1728. PubMed ID: 12468525
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood flow heterogeneity versus cerebral hypoperfusion revealed by fractal analysis on (99m)Tc-HMPAO SPECT.
    Chung HW
    J Nucl Med; 2003 Nov; 44(11):1874. PubMed ID: 14602874
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
    Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J
    Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Content of delusional thoughts in Alzheimer's disease and assessment of content-specific brain dysfunctions with BEHAVE-AD-FW and SPECT.
    Nakatsuka M; Meguro K; Tsuboi H; Nakamura K; Akanuma K; Yamaguchi S
    Int Psychogeriatr; 2013 Jun; 25(6):939-48. PubMed ID: 23433495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F; Koulibaly PM; Rodriguez G; Benoit M; Girtler N; Robert PH; Brugnolo A; Darcourt J
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
    Elgh E; Sundström T; Näsman B; Ahlström R; Nyberg L
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease: correlation between neuropsychiatric evaluation and CBF images.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Sato M; Fukuda H
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):228-32. PubMed ID: 10071106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detecting regional cerebral blood flow changes in Alzheimer's patients after milameline treatment: activation or baseline SPECT?
    Zheng XM
    J Nucl Med Technol; 2002 Sep; 30(3):118-22. PubMed ID: 12186960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of cerebral blood flow in dementia.
    Kuikka JT
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):516. PubMed ID: 15750828
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.
    Fukuchi K; Hashikawa K; Seike Y; Moriwaki H; Oku N; Ishida M; Fujita M; Uehara T; Tanabe H; Kusuoka H; Nishimura T
    J Nucl Med; 1997 Mar; 38(3):467-70. PubMed ID: 9074540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of cerebral blood flow: a fractal approach.
    Kuikka JT; Hartikainen P
    Nuklearmedizin; 2000; 39(2):37-42. PubMed ID: 10768168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT.
    Bartenstein P; Minoshima S; Hirsch C; Buch K; Willoch F; Mösch D; Schad D; Schwaiger M; Kurz A
    J Nucl Med; 1997 Jul; 38(7):1095-101. PubMed ID: 9225797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
    Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
    J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease.
    Ashford JW; Shih WJ; Coupal J; Shetty R; Schneider A; Cool C; Aleem A; Kiefer VH; Mendiondo MS; Schmitt FA
    J Nucl Med; 2000 Jan; 41(1):57-64. PubMed ID: 10647605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.